Bio-Rad Laboratories BIO Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's retained earnings?
- Bio-Rad Laboratories (BIO) reported retained earnings of $7.65B in Q1 2026.
- How has Bio-Rad Laboratories's retained earnings changed year-over-year?
- Bio-Rad Laboratories's retained earnings increased by 2.3% year-over-year, from $7.48B to $7.65B.
- What is the long-term trend for Bio-Rad Laboratories's retained earnings?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's retained earnings has grown at a -2.5% compound annual growth rate (CAGR), from $9.27B to $8.18B.
- What does retained earnings mean?
- The total accumulated profits the company has kept and reinvested rather than paying out as dividends.
- How do you interpret retained earnings?
- Consistent growth in retained earnings is a strong indicator of long-term profitability and internal capital generation.
- How does retained earnings compare across companies?
- A standard measure of historical performance and financial health across all industries.